Estimating the use of veterinary medicines in the European union

被引:125
作者
Kools, Stefan A. E. [1 ]
Moltmann, Johann F. [1 ]
Knacker, Thomas [1 ]
机构
[1] ECT Oekotoxikol GmbH, D-65439 Floersheim, Germany
关键词
veterinary pharmaceuticals; antibiotics; antiparasitics; hormones; environmental risk assessment; use volumes; Europe; prioritisation methodology;
D O I
10.1016/j.yrtph.2007.06.003
中图分类号
DF [法律]; D9 [法律]; R [医药、卫生];
学科分类号
0301 ; 10 ;
摘要
Risk-based ranking is a procedure that ranks active substances according to their potential environmental risk, which can be used to prioritise effort in environmental risk assessment procedures. An important aspect in this procedure is the extent of use of the active substance. However, use volume data for veterinary pharmaceuticals are generally not publicly available. Therefore, the use of several groups of pharmaceuticals was estimated. For this, available data were collected from different sources and used to calculate the average use, related with the total meat production in the respective countries. Then, an extrapolation, based on food-stuff production data, yields a rough estimate of the use volume for all European countries, largely based on 2004 data. The estimated use was 5393 tons antibiotics, 194 tons antiparasitics and 4.6 tons hormones, 221 tons to treat the alimentary tract and metabolism related disorders, 120 tons CNS active substances, 60 tons of substances used for blood and blood forming organs and 52 tons for muscles and skeleton related disorders. In total, an estimated 6051 tons of active substances in veterinary medicines were used in the European Union. We discuss available data sources and quality, our method and possible refinement of our approach. Environmental risk-based ranking procedures of veterinary substances would benefit from more detailed use data. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:59 / 65
页数:7
相关论文
共 36 条
[1]   Veterinary drug usage and antimicrobial resistance in bacteria of animal origin [J].
Aarestrup, FM .
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2005, 96 (04) :271-281
[2]  
[Anonymous], 2002, REV VET MED ENV
[3]   Veterinary medicines in the environment [J].
Boxall, ABA ;
Fogg, LA ;
Blackwell, PA ;
Kay, P ;
Pemberton, EJ ;
Croxford, A .
REVIEWS OF ENVIRONMENTAL CONTAMINATION AND TOXICOLOGY, VOL 180, 2004, 180 :1-91
[4]   Prioritising veterinary medicines according to their potential indirect human exposure and toxicity profile [J].
Capleton, AC ;
Courage, C ;
Rumsby, P ;
Holmes, P ;
Stutt, E ;
Boxall, ABA ;
Levy, LS .
TOXICOLOGY LETTERS, 2006, 163 (03) :213-223
[5]  
Carvalho MLS, 2013, THESIS
[6]   Pharmaceuticals in the environment - A human risk? [J].
Christensen, FM .
REGULATORY TOXICOLOGY AND PHARMACOLOGY, 1998, 28 (03) :212-221
[7]  
DANMAP, 2004, US ANT AG OCC ANT RE
[8]   Physiological and reproductive effects of beta adrenergic receptor antagonists in Daphnia magna [J].
Dzialowski, EM ;
Turner, PK ;
Brooks, BW .
ARCHIVES OF ENVIRONMENTAL CONTAMINATION AND TOXICOLOGY, 2006, 50 (04) :503-510
[9]  
*EMEA, 1999, EMEACVMP34299CORRFIN
[10]  
*EMEA, 2006, EMEACVMPERA418282200, P59